Noteworthy, though, was that parenteral immunization induced a faster and stronger PSP-specific IgG response than the oral immunization, which was not translated to a better protection compared to oral immunization, which achieved comparable efficacy despite lower serum IgG levels at the time of infection (50), strongly supporting the benefits of mucosal IgA Abs. The gene discussed is CD79A; the disease is infection.